Atropine (Atropine Lamar)
Atropine
Lamar International (Pty) Ltd
Registration
- Applicant
- Lamar International (Pty) Ltd
- Registrations
- 2
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Atropine 0,5 mg/ml lamar EACH 1,0 ml SOLUTION CONTAINS: ATROPINE SULPHATE 0,5 mg | 0,5 mg/ml | 60006760/5.4/0067 | Registered | Not determined | None |
| Atropine 1 mg/ml lamar EACH 1,0 ml SOLUTION CONTAINS: ATROPINE SULPHATE 1,0 mg | 1 mg/ml | 60006860/5.4/0068 | Registered | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
Listings for this ingredient that could not be applied to this product
S4: Atropine
- when intended for use in injections. (S2)
- except when intended for use in ophthalmic preparations. (S3)
Consolidated Schedules 06 July 2026, lines 5387 to 5391
S3: Atropine
- when intended for use in ophthalmic preparations; (S2)
- except when intended for use in injections. (S4)
Consolidated Schedules 06 July 2026, lines 3150 to 3154
S2: Atropine
- when intended for use in ophthalmic preparations; (S3)
- when intended for use in injections. (S4)
Consolidated Schedules 06 July 2026, lines 1631 to 1635
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
[(1S,5R)-8-Methyl-8-azabicyclo[3.2.1]octan-3-yl] 3-hydroxy-2-phenylpropanoate
Drag to rotate. Structure from PubChem CID 174174.
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.